Latest Ventures
Cardiff University has an excellent track record of commercially exploiting the outcomes of its research. Forming a company to exploit University know-how or expertise is one of the routes available, and is managed through a close working relationship with Fusion IP. Licensing and royalty agreements, which enable businesses to use Cardiff research commercially, bring enormous benefits to a range of companies. Examples of recent successes are shown below along with current opportunities. If you are interested in obtaining further information please contact us.
Latest News
New collaboration with GE Healthcare
New initiative agreed between Cardiff University and GE Healthcare
University's Anti-Viral Drug Acquired In £1.6bn takeover
Bristol-Myers Squibb secures rights to INX-189 through Inhibitex Buyout
Spinout News
Cardiff Spin-Out i2L Extends Into USA Via Acquisition of ICR
Fusion spin-out company i2L seeks to expand its European based agrochemicals, biocide and regulatory operations into the USA
MedaPhor Raises £1m
Successful fundraising for ultrasound training simulator spin-out
New Spin-Out: Nanotether Discovery Services
Spin-out from School of Biosciences offers exciting drug discovery acceleration
Asalus: 'Innervision' Set For Clinical Trials
Cardiff University spin-out to begin first 'in man' clinical trials for revolutionary smoke removal device
Recently Licensed Technologies
- Cardiff University Licensing Summary: Academic Year 2008/09
- Protide Technology Licensed To NuCana Biomed Ltd
Current Licensing Opportunities
For further information please contact the Technology Transfer Group